This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
In this session, Dr. Chris Metzger performs TWO Shockwave IVL cases – one calcified CFA and one bilateral aortoiliac occlusive disease (AIOD). Drs. Craig Walker, George Adams, Constantino Pena, Ehrin Armstrong and Michael Lichtenberg provide...
In this session, Dr. Chris Metzger performs TWO Shockwave IVL cases – one calcified CFA and one bilateral aortoiliac occlusive disease (AIOD). Drs. Craig Walker, George Adams, Constantino Pena, Ehrin Armstrong and Michael Lichtenberg provide...
This article discusses the importance of lesion preparation and reviews the technique and the materials to reduce the complications following inflation and deflation of the balloon with special attention to dissection in the BTK district.
This article discusses the importance of lesion preparation and reviews the technique and the materials to reduce the complications following inflation and deflation of the balloon with special attention to dissection in the BTK district.
Complex CLI intervention performed at Advanced Cardiac and Vascular Centers for Amputation Prevention, an outpatient CLI center. Patient with RC 4 presentation requiring ultrasound guided access at 4 locations for successful laser...
Complex CLI intervention performed at Advanced Cardiac and Vascular Centers for Amputation Prevention, an outpatient CLI center. Patient with RC 4 presentation requiring ultrasound guided access at 4 locations for successful laser...
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
CLI patients with no cardiac history undergoing limb salvage surgery have a high prevalence of asymptomatic ischemia-producing coronary stenosis, which may put them at increased risk.
CLI patients with no cardiac history undergoing limb salvage surgery have a high prevalence of asymptomatic ischemia-producing coronary stenosis, which may put them at increased risk.
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
Brandner and Adams discuss a case that highlights the use of Tack implants to address two grade D dissections of the mid-right superficial femoral artery (SFA) following balloon angioplasty.
Brandner and Adams discuss a case that highlights the use of Tack implants to address two grade D dissections of the mid-right superficial femoral artery (SFA) following balloon angioplasty.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...